M. Kłusek, K. Chawrylak, J. Kuszneruk, M. Kubas, and K. Krzemińska, “Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review”, Qual Sport, vol. 18, p. 53252, Jul. 2024.